Program Director Tero Piispanen, HealthBIO?s national coordinator
Turku Science Park Ltd
Postal address
Street Name
Itäinen Pitkäkatu
Number
4B
Town
Turku
Postal Code/Cedex
20520
Country
Finland
Basic characteristics of RDC
RDC participants' structure
Number of local authorities representatives
Number of research entities
Number of companies
RDC human resources
Number of employees
Number of researchers
Sector of activity (NACE)
Manufacture of basic pharmaceutical products and pharmaceuti
Scientific research and development
Human health activities
RDC type of development
RDC stage of development
Management structure
Cluster strategy
RDC Activities
Areas of cooperation in the frame of cluster activities.
Communication and information
Financing of the cluster's activities
Structure of cluster financing (own resources/outer resources)
Outer private financial resources received used for common projects/activities during the last 3 years
Outer public financial resources received used for common projects/activities during the last 3 years
Spendings on common R&D projects
Spendings on investments in common cluster infrastructure during the last 3 years (common infrastructure)
Cluster internationalization
Marketing and PR
Trainings
RDC Impact and results
Knowledge and innovation development
% of cluster SME innovating in-house in the last 3 years
% of cluster SME cooperating with R&D organizations (based on agreements) in the last 3 years
Number of start-ups in cluster in all cluster history
Number of cluster transnational cooperation agreements
Increase of the regional and branch competitiveness
Increase of employment within cluster for the last 3 years no increase
Increase in number of new entities joining the cluster (research organizations, companies) in the last 3 years
Transnational sales as a % of total cluster companies turnover for the last 3 years
Sales of new to market products as % of total cluster companies turnover
FDI in region in sector specific to cluster in the last 3 years
RDC Activities
Most important project in the last 3 years (started or completed) having impact on cluster development including results, source of funding and approx. budget.
Bio-Inno is a joint project between Helsinki University of Technology and University of Helsinki which studies and develops business competence and innovation activity in bio- and bio-oriented companies. The project will be realized in cooperation with Stanford University and Berlin University of Technology. The project started in the beginning of the year 2009 and will continue until the end of the year 2010. The total budget of the project is 920 000 Euros.
Pharmaceutical Gateway China-Finland/Europe is a cooperative HealthBio Cluster spearhead project of the University of Kuopio and Kuopio Innovation Ltd. Its overall aim is to increase pharmaceutical cooperation between Finland and China. Finnish and Chinese universities, pharmaceutical companies and development organizations are participating in this programme.
his national spearhead project (2009-2011) works to realize the plans of "Measurement of human being" of the HealthBio program. It aims at the development of novel, cost-efficient, disposable antibody-based printable biosensor technology mainly applicable for human diagnostics. It aims to connect bio-, nano- and information technologies with the needs of diagnostics industry.
Most important research results implemented within cluster by more than one enterprise (technical and organizational innovations, technology transfers, etc) Short description of the project and results
* Biomarker discovery for personalised health care
* Antibody engineering and antibody libraries
* Development of printable immunosensors for point-of-care testing
*
Biocompatible materials for printed diagnostics
*
Detection technologies and signal processing
*
Wireless data transfer and links to health data systems
*
Prototype testing and cost-effective manufacturing methods
*
Support to commercialization
Most important research infrastructure available (with special attention on industrial applications and availability for transnational collaboration) (without office equipment) Short description of the laboratory
Please specify infrastructure you need access to in particular research infrastructure (if any)
